These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20624125)

  • 1. Cripto-1: an embryonic gene that promotes tumorigenesis.
    de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
    Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cripto monoclonal antibodies.
    Hu XF; Xing PX
    Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Cripto-1 in stem cell maintenance and malignant progression.
    Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
    Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
    Liguori GL; Borges AC; D'Andrea D; Liguoro A; Gonçalves L; Salgueiro AM; Persico MG; Belo JA
    Dev Biol; 2008 Mar; 315(2):280-9. PubMed ID: 18241853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evolving web of signaling networks regulated by Cripto-1.
    Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C
    Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto as a target for cancer immunotherapy.
    Hu XF; Xing PX
    Expert Opin Ther Targets; 2005 Apr; 9(2):383-94. PubMed ID: 15934922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.
    Klauzinska M; McCurdy D; Rangel MC; Vaidyanath A; Castro NP; Shen MM; Gonzales M; Bertolette D; Bianco C; Callahan R; Salomon DS; Raafat A
    Am J Pathol; 2015 Nov; 185(11):2907-22. PubMed ID: 26429739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche.
    Miharada K; Karlsson G; Rehn M; Rörby E; Siva K; Cammenga J; Karlsson S
    Ann N Y Acad Sci; 2012 Aug; 1266():55-62. PubMed ID: 22901256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.
    Strizzi L; Bianco C; Raafat A; Abdallah W; Chang C; Raafat D; Hirota M; Hamada S; Sun Y; Normanno N; Callahan R; Hinck L; Salomon D
    J Cell Sci; 2005 Oct; 118(Pt 20):4633-43. PubMed ID: 16176936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional redundancy of EGF-CFC genes in epiblast and extraembryonic patterning during early mouse embryogenesis.
    Chu J; Shen MM
    Dev Biol; 2010 Jun; 342(1):63-73. PubMed ID: 20346354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis.
    Shukla A; Ho Y; Liu X; Ryscavage A; Glick AB
    Mol Cancer Res; 2008 Mar; 6(3):509-16. PubMed ID: 18337457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.
    Rangel MC; Karasawa H; Castro NP; Nagaoka T; Salomon DS; Bianco C
    Am J Pathol; 2012 Jun; 180(6):2188-200. PubMed ID: 22542493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.
    Wu Z; Li G; Wu L; Weng D; Li X; Yao K
    BMC Cancer; 2009 Sep; 9():315. PubMed ID: 19732464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epidermal growth factor family gene members in early mouse development.
    Johnson SE; Rothstein JL; Knowles BB
    Dev Dyn; 1994 Nov; 201(3):216-26. PubMed ID: 7881126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-type specific regulation of myostatin signaling.
    Kemaladewi DU; de Gorter DJ; Aartsma-Rus A; van Ommen GJ; ten Dijke P; 't Hoen PA; Hoogaars WM
    FASEB J; 2012 Apr; 26(4):1462-72. PubMed ID: 22202673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRIPTO3, a presumed pseudogene, is expressed in cancer.
    Sun C; Orozco O; Olson DL; Choi E; Garber E; Tizard R; Szak S; Sanicola M; Carulli JP
    Biochem Biophys Res Commun; 2008 Dec; 377(1):215-20. PubMed ID: 18835250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
    Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
    J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
    Gray PC; Shani G; Aung K; Kelber J; Vale W
    Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.